Kim Cocks

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · The Lancet · 2010 · 571 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30

Kim Cocks, Madeleine King, Galina Velikova et al. · European Journal of Cancer · 2012 · 565 citations · Full text

Pharmacy, Oncology, Change Measurement +15

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

Kevin J. Harrington, Robert L. Ferris, George R. Blumenschein et al. · The Lancet Oncology · 2017 · 430 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma

Kim Cocks, D. Cohen, Orhan Sezer et al. · European Journal of Cancer · 2007 · 251 citations

Medicine, Oncology, Health Assessment +13

Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial

Galina Velikova, Ada Keding, Clare Harley et al. · European Journal of Cancer · 2010 · 181 citations

Medicine, Oncology, Continuity Of Care +12